Skip to main content
. 2014 Dec 10;35(2):83–93. doi: 10.1007/s40261-014-0240-z

Fig. 2.

Fig. 2

Deterministic sensitivity analysis. AE adverse event, BTX botulinum toxin, EQ5D European Quality of Life questionnaire in five dimensions, ICER incremental cost-effectiveness ratio